Insulin Glargine vs Glucagon
Head-to-head comparison of Insulin Glargine (Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)) and Glucagon (Glucagon) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Insulin Glargine | Glucagon |
|---|---|---|
| Category | Diabetes & Metabolic | Diabetes & Metabolic |
| Full Name | Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog) | Glucagon |
| Molecular Weight | 6063.6 Da | 3482.75 |
| Half-Life | About 12-24 hours | 5-10 min |
| Amino Acids | 51 | 29 |
| Typical Dose | 0.1-0.2 U/kg once daily | 1 mg IM/SC for severe hypoglycemia or 3 mg intranasal |
| Route | Subcutaneous | IM|SC|IN|IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 13000 | 93 |
| Research Status | Approved | Approved |
Insulin Glargine Benefits
- ✓Once-daily basal coverage
- ✓Smooth action profile
- ✓Lower nocturnal hypoglycemia risk
- ✓Improves fasting glucose control
Glucagon Benefits
- ✓rapid hypoglycemia reversal
- ✓raises plasma glucose
- ✓useful in emergency rescue
Insulin Glargine Dosing
Inject SC once daily at the same time each day|Titrate every 3-4 days to fasting glucose targets|Can be combined with prandial insulin
Glucagon Dosing
1 mg IM/SC|3 mg intranasal
Insulin Glargine Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Glucagon Side Effects
- ⚠nausea
- ⚠vomiting
Research Overview
Insulin Glargine
Clinical and translational studies support its use as a basal comparator because of prolonged absorption and stable glycemic control. It is heavily used in basal-bolus regimen research and insulin-delivery optimization studies.
Glucagon
Clinical and emergency medicine use is well established for severe hypoglycemia, with newer stable formulations improving ease of administration.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.